L'USAID considère des facteurs comme l'éducation, l'emploi et l'accès aux services de santé.
Facteurs socio-économiquesÉducation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Agency for International Development (USA) : Questions médicales les plus fréquentes",
"headline": "Agency for International Development (USA) : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Agency for International Development (USA) : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-08-04",
"dateModified": "2024-11-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Agency for International Development (USA)"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Agences gouvernementale américaines",
"url": "https://recherchemedicale.com/mesh/D037041",
"about": {
"@type": "MedicalCondition",
"name": "Agences gouvernementale américaines",
"code": {
"@type": "MedicalCode",
"code": "D037041",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.540.348.500.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Agency for International Development (USA)",
"alternateName": "United States Agency for International Development",
"code": {
"@type": "MedicalCode",
"code": "D054702",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robbert J Duvivier",
"url": "https://recherchemedicale.com/author/Robbert%20J%20Duvivier",
"affiliation": {
"@type": "Organization",
"name": "Foundation for Advancement of International Medical Education and Research, Philadelphia, Pennsylvania."
}
},
{
"@type": "Person",
"name": "John R Boulet",
"url": "https://recherchemedicale.com/author/John%20R%20Boulet",
"affiliation": {
"@type": "Organization",
"name": "Foundation for Advancement of International Medical Education and Research, Philadelphia, Pennsylvania; jboulet@faimer.org."
}
},
{
"@type": "Person",
"name": "Jingjing Shang",
"url": "https://recherchemedicale.com/author/Jingjing%20Shang",
"affiliation": {
"@type": "Organization",
"name": "Center for Health Policy, Columbia University School of Nursing, 560 West 168th Street, Mail Code 6, New York 10032, NY, USA. Electronic address: js4032@cumc.columbia.edu."
}
},
{
"@type": "Person",
"name": "Ashley M Chastain",
"url": "https://recherchemedicale.com/author/Ashley%20M%20Chastain",
"affiliation": {
"@type": "Organization",
"name": "Center for Health Policy, Columbia University School of Nursing, 560 West 168th Street, Mail Code 6, New York 10032, NY, USA."
}
},
{
"@type": "Person",
"name": "Andrew W Dick",
"url": "https://recherchemedicale.com/author/Andrew%20W%20Dick",
"affiliation": {
"@type": "Organization",
"name": "The RAND Corporation, 20 Park Plaza, 9th Floor, Suite 920, Boston 02116, MA, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Establishing a national biosafety and biosecurity agency for the United States.",
"datePublished": "2024-10-17",
"url": "https://recherchemedicale.com/article/39483610",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fbioe.2024.1474120"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development and the social sciences: international agencies in Brazilian favelas in the 1960s.",
"datePublished": "2023-05-15",
"url": "https://recherchemedicale.com/article/37194751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/S0104-59702023000100015"
}
},
{
"@type": "ScholarlyArticle",
"name": "Availability of comprehensive emergency obstetric and neonatal care in developing regions in Ethiopia: lessons learned from the USAID transform health activity.",
"datePublished": "2022-11-02",
"url": "https://recherchemedicale.com/article/36324131",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12913-022-08712-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Small molecule protein kinase inhibitors approved by regulatory agencies outside of the United States.",
"datePublished": "2023-07-15",
"url": "https://recherchemedicale.com/article/37454916",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.phrs.2023.106847"
}
},
{
"@type": "ScholarlyArticle",
"name": "Strategies Used by Local Law Enforcement Agencies to Prevent Overservice of Alcohol in the United States.",
"datePublished": "2022-08-25",
"url": "https://recherchemedicale.com/article/36006532",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10900-022-01132-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://recherchemedicale.com/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organismes",
"item": "https://recherchemedicale.com/mesh/D009938"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gouvernement",
"item": "https://recherchemedicale.com/mesh/D006076"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agences gouvernementale américaines",
"item": "https://recherchemedicale.com/mesh/D037041"
},
{
"@type": "ListItem",
"position": 6,
"name": "Agency for International Development (USA)",
"item": "https://recherchemedicale.com/mesh/D054702"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Agency for International Development (USA) - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Agency for International Development (USA)",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-01-23",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Agency for International Development (USA)",
"description": "Comment évaluer l'impact de l'USAID sur la santé mondiale ?\nQuels outils utilise l'USAID pour le diagnostic des besoins ?\nComment l'USAID identifie-t-elle les maladies prioritaires ?\nQuels critères l'USAID utilise-t-elle pour le diagnostic des projets ?\nComment l'USAID évalue-t-elle les systèmes de santé ?",
"url": "https://recherchemedicale.com/mesh/D054702#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Agency for International Development (USA)",
"description": "Quels symptômes l'USAID cible-t-elle dans ses programmes ?\nComment l'USAID aborde les symptômes de maladies tropicales ?\nQuels symptômes sont liés à l'accès à l'eau potable ?\nComment l'USAID traite-t-elle les symptômes de VIH/SIDA ?\nQuels symptômes sont observés dans les crises humanitaires ?",
"url": "https://recherchemedicale.com/mesh/D054702#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Agency for International Development (USA)",
"description": "Quelles stratégies l'USAID utilise-t-elle pour la prévention des maladies ?\nComment l'USAID promeut-elle l'hygiène ?\nQuels programmes de prévention l'USAID met-elle en place pour le VIH ?\nComment l'USAID aborde-t-elle la prévention de la malnutrition ?\nQuelles initiatives l'USAID prend-elle pour la santé reproductive ?",
"url": "https://recherchemedicale.com/mesh/D054702#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Agency for International Development (USA)",
"description": "Quels traitements l'USAID soutient-elle pour la tuberculose ?\nComment l'USAID aide-t-elle au traitement du paludisme ?\nQuels traitements l'USAID propose-t-elle pour la malnutrition ?\nComment l'USAID soutient-elle les soins maternels ?\nQuels traitements l'USAID offre-t-elle pour les maladies chroniques ?",
"url": "https://recherchemedicale.com/mesh/D054702#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Agency for International Development (USA)",
"description": "Quelles complications l'USAID surveille-t-elle dans les soins de santé ?\nComment l'USAID gère-t-elle les complications de la malnutrition ?\nQuelles complications sont liées au VIH/SIDA ?\nComment l'USAID aborde-t-elle les complications des maladies tropicales ?\nQuelles complications l'USAID surveille-t-elle en cas de crise humanitaire ?",
"url": "https://recherchemedicale.com/mesh/D054702#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Agency for International Development (USA)",
"description": "Quels facteurs de risque l'USAID identifie-t-elle pour la santé ?\nComment l'USAID évalue-t-elle les facteurs de risque environnementaux ?\nQuels comportements à risque l'USAID cible-t-elle ?\nComment l'USAID aborde-t-elle les facteurs de risque liés à la santé mentale ?\nQuels facteurs socio-économiques l'USAID considère-t-elle ?",
"url": "https://recherchemedicale.com/mesh/D054702#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'impact de l'USAID sur la santé mondiale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'impact est évalué par des indicateurs de santé, des études de cas et des analyses de données."
}
},
{
"@type": "Question",
"name": "Quels outils utilise l'USAID pour le diagnostic des besoins ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID utilise des enquêtes, des analyses de données et des consultations communautaires."
}
},
{
"@type": "Question",
"name": "Comment l'USAID identifie-t-elle les maladies prioritaires ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID identifie les maladies prioritaires par des études épidémiologiques et des consultations."
}
},
{
"@type": "Question",
"name": "Quels critères l'USAID utilise-t-elle pour le diagnostic des projets ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent l'impact potentiel, la durabilité et l'alignement avec les besoins locaux."
}
},
{
"@type": "Question",
"name": "Comment l'USAID évalue-t-elle les systèmes de santé ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par des audits, des analyses de performance et des enquêtes de satisfaction."
}
},
{
"@type": "Question",
"name": "Quels symptômes l'USAID cible-t-elle dans ses programmes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID cible des symptômes liés à la malnutrition, aux maladies infectieuses et aux soins maternels."
}
},
{
"@type": "Question",
"name": "Comment l'USAID aborde les symptômes de maladies tropicales ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID met en œuvre des programmes de prévention et de traitement pour les maladies tropicales."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'accès à l'eau potable ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maladies diarrhéiques, des infections et des problèmes de santé liés à l'hygiène."
}
},
{
"@type": "Question",
"name": "Comment l'USAID traite-t-elle les symptômes de VIH/SIDA ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID fournit des traitements antirétroviraux et des programmes de sensibilisation et de prévention."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont observés dans les crises humanitaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la malnutrition, les maladies infectieuses et les traumatismes psychologiques."
}
},
{
"@type": "Question",
"name": "Quelles stratégies l'USAID utilise-t-elle pour la prévention des maladies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID utilise l'éducation, la vaccination et l'amélioration des infrastructures sanitaires."
}
},
{
"@type": "Question",
"name": "Comment l'USAID promeut-elle l'hygiène ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID promeut l'hygiène par des campagnes de sensibilisation et des programmes d'accès à l'eau."
}
},
{
"@type": "Question",
"name": "Quels programmes de prévention l'USAID met-elle en place pour le VIH ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID met en place des programmes de sensibilisation, de dépistage et de traitement préventif."
}
},
{
"@type": "Question",
"name": "Comment l'USAID aborde-t-elle la prévention de la malnutrition ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID aborde la malnutrition par des programmes d'éducation nutritionnelle et de soutien alimentaire."
}
},
{
"@type": "Question",
"name": "Quelles initiatives l'USAID prend-elle pour la santé reproductive ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID prend des initiatives pour l'accès à la contraception et l'éducation à la santé reproductive."
}
},
{
"@type": "Question",
"name": "Quels traitements l'USAID soutient-elle pour la tuberculose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID soutient des programmes de dépistage, de traitement et de sensibilisation à la tuberculose."
}
},
{
"@type": "Question",
"name": "Comment l'USAID aide-t-elle au traitement du paludisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID fournit des moustiquaires, des médicaments et des programmes de prévention du paludisme."
}
},
{
"@type": "Question",
"name": "Quels traitements l'USAID propose-t-elle pour la malnutrition ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID propose des suppléments nutritionnels et des programmes d'éducation alimentaire."
}
},
{
"@type": "Question",
"name": "Comment l'USAID soutient-elle les soins maternels ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID soutient la formation des sages-femmes et l'accès aux soins prénatals et postnatals."
}
},
{
"@type": "Question",
"name": "Quels traitements l'USAID offre-t-elle pour les maladies chroniques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID offre des programmes de gestion des maladies chroniques et d'éducation à la santé."
}
},
{
"@type": "Question",
"name": "Quelles complications l'USAID surveille-t-elle dans les soins de santé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID surveille les complications liées aux maladies infectieuses et aux soins maternels."
}
},
{
"@type": "Question",
"name": "Comment l'USAID gère-t-elle les complications de la malnutrition ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID gère les complications par des traitements médicaux et des programmes de réhabilitation nutritionnelle."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées au VIH/SIDA ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les infections opportunistes et les maladies chroniques associées."
}
},
{
"@type": "Question",
"name": "Comment l'USAID aborde-t-elle les complications des maladies tropicales ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID aborde les complications par des traitements ciblés et des programmes de prévention."
}
},
{
"@type": "Question",
"name": "Quelles complications l'USAID surveille-t-elle en cas de crise humanitaire ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID surveille les complications telles que la malnutrition aiguë et les maladies infectieuses."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque l'USAID identifie-t-elle pour la santé ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID identifie des facteurs tels que la pauvreté, l'accès limité aux soins et l'éducation insuffisante."
}
},
{
"@type": "Question",
"name": "Comment l'USAID évalue-t-elle les facteurs de risque environnementaux ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID évalue les facteurs environnementaux par des études d'impact et des analyses de données."
}
},
{
"@type": "Question",
"name": "Quels comportements à risque l'USAID cible-t-elle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID cible des comportements tels que la consommation de drogues, le tabagisme et les rapports sexuels non protégés."
}
},
{
"@type": "Question",
"name": "Comment l'USAID aborde-t-elle les facteurs de risque liés à la santé mentale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID aborde ces facteurs par des programmes de sensibilisation et d'accès aux soins psychologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs socio-économiques l'USAID considère-t-elle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'USAID considère des facteurs comme l'éducation, l'emploi et l'accès aux services de santé."
}
}
]
}
]
}
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry
2022-04-29
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry
2022-04-29
Center for Health Policy, Columbia University School of Nursing, 560 West 168th Street, Mail Code 6, New York 10032, NY, USA. Electronic address: js4032@cumc.columbia.edu.
Publications dans "Agency for International Development (USA)" :
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Publications dans "Agency for International Development (USA)" :
The rapid advancement of biological research and biotechnology requires a novel and robust regulatory agency to ensure uniform biosafety and biosecurity governance in the United States. The current fr...
An analysis is presented of the work of three international entities in Brazilian favelas in the 1960s: Brasil-Estados Unidos Movimento, Desenvolvimento e Organização de Comunidade; Ação Comunitária d...
In collaboration with its partners, the Ethiopian government has been implementing standard Emergency Obstetric and Neonatal Care Services (CEmONC) since 2010. However, limited studies documented the ...
At baseline, we conducted a cross-sectional study covering 15 public hospitals in four developing regions of Ethiopia (Somali, Afar, Beneshangul Gumz, and Gambella). Then, clinical mentorship was intr...
At baseline, six out of the 15 hospitals performed all the nine CEmONC signal functions, and one-third of the signal functions were performed in all hospitals. Cesarean Section service was available i...
The availability of CEmONC signal functions in the supported hospitals did not change the occurrence of maternal death and stillbirth. This indicates the need for investigating underlying and proximal...
Owing to genetic alterations and overexpression, the dysregulation of protein kinases plays a significant role in the pathogenesis of many autoimmune and neoplastic disorders and protein kinase antago...
Overservice of alcohol, defined as commercial provision of alcohol to an individual who is obviously intoxicated, is illegal in most states and contributes to motor vehicle crashes and violence. Law e...
To describe characteristics, trends, and outcomes of international gestational surrogacy cycles in the United States (US)....
Retrospective cohort study....
All assisted reproductive technology cycles in the US reported to the Society for Assisted Reproductive Technology Clinic Outcome Reporting Systems that included an embryo transfer to a gestational ca...
International versus US intended parents....
Cycle characteristics, geographic distributions, and obstetrical outcomes....
Of 40,177 embryo transfers to a gestational carrier from 2014-2020, 32% were for international intended parents. The number and percent of international intended parents gestational carrier cycles inc...
An increasing number of international intended parents are utilizing gestational surrogacy in the US and more frequently using cost-enhancing specialized treatment techniques. This increase is potenti...
This study describes the supply, distribution, and characteristics of international medical graduate (IMG) psychiatrists who provide services in the USA....
Cross-sectional study design, using descriptive statistics based on combined data from the American Medical Association (2020 Physician Masterfile) and the Educational Commission for Foreign Medical G...
International medical graduates continue to make significant contributions to the US physician workforce. As a group, they represent 29% of active psychiatrists in the USA, compared to 23% in all othe...
This study provides an overview of the psychiatric workforce in the USA, quantifying the specific contribution of IMGs. Several factors, including immigration policies, continued expansion of US medic...
Injury is both a national and international epidemic that affects people of all age, race, religion, and socioeconomic class. Injury was the fourth leading cause of death in the United States (U.S.) i...
Gene therapy, altering the genes inside human cells, has recently emerged as an alternative for preventing and treating disease. Concerns have been expressed about the clinical value and the high cost...
This study assessed the characteristics of the clinical trials, authorizations, and prices of gene therapies in the United States and the European Union....
We collected regulatory information from the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) and manufacturer-listed prices from the United States, UK, and Germany. Descript...
As of January 1, 2022, the FDA and EMA authorized 8 and 10 gene therapies, respectively. The FDA and EMA granted orphan designation to all gene therapies except talimogene laherparepvec. Pivotal clini...
Gene therapy is used to treat incurable diseases that affect only a small number of patients (orphan diseases). Based on this, they are approved by the EMA and FDA with insufficient clinical evidence ...
Home health care agencies (HHAs) are skilled care providers for Medicare home health beneficiaries in the United States. Rural HHAs face different challenges from their urban counterparts in deliverin...
Systematic review guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and using the Newcastle-Ottawa Scale (NOS) for quality appraisal....
Care provided by urban and rural HHAs....
We conducted a systematic search for English-language peer-reviewed articles after 2010 on differences in urban and rural care provided by U.S. HHAs. We screened 876 studies, conducted full-text abstr...
Twelve studies were included; 7 focused on patient-level analyses and 5 were HHA-level. Nine studies were cross-sectional and 3 used cohorts. Urban and rural differences were measured primarily using ...
This review highlights similar urban/rural disparities in home health care quality and utilization as identified in previous decades. Variables used to measure the access to and quality of care by HHA...